Last reviewed · How we verify

NCT07126600

Data Collection for Echocardiography-Based Software Assessment

Completed Last updated 24 December 2025
What this trial tests

trial testing No investigational intervention administered in Atrial Fibrillation in 100 participants. Completed in 17 December 2025.

Timeline
11 July 2025
Primary endpoint
19 November 2025
17 December 2025

Quick facts

Lead sponsorAnumana, Inc.
StatusCompleted
Study typeOBSERVATIONAL
Enrollment100
Start date11 July 2025
Primary completion19 November 2025
Estimated completion17 December 2025
Sites6 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Anumana, Inc.

Who can join

18 and older, any sex, with Atrial Fibrillation or Left Atrial Appendage Closure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective, observational study collecting data from routine clinical care. The information gathered will be used to support the evaluation of a software-based tool. No investigational procedures or treatments are introduced, and all data are obtained as part of standard-of-care activities.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Atrial Fibrillation

Currently open trials in the same condition.

Other Anumana, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07126600.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing